IN2013CH04706A - - Google Patents

Info

Publication number
IN2013CH04706A
IN2013CH04706A IN4706CH2013A IN2013CH04706A IN 2013CH04706 A IN2013CH04706 A IN 2013CH04706A IN 4706CH2013 A IN4706CH2013 A IN 4706CH2013A IN 2013CH04706 A IN2013CH04706 A IN 2013CH04706A
Authority
IN
India
Prior art keywords
disorders
azacytidine
lyophilized composition
stable lyophilized
cancer
Prior art date
Application number
Inventor
Pradeep Shivakumar
Nagaraju Dasari
Ravi Kishore
Rizwan Ahmed
Akshay Kant Chaturvedi
Original Assignee
Shilpa Medicare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shilpa Medicare Ltd filed Critical Shilpa Medicare Ltd
Priority to IN4706CH2013 priority Critical patent/IN2013CH04706A/en
Publication of IN2013CH04706A publication Critical patent/IN2013CH04706A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a stable lyophilized composition comprising 5-Azacytidine Form I, and process for preparing thereof. The present invention provides a stable lyophilized composition comprising 5-Azacytidine Form I, and the methods of using a stable lyophilized composition comprising Crystalline 5-Azacytidine Form I for parenteral administration, provided herein to treat diseases or disorders including, e.g., cancer, disorders related to abnormal cell proliferation, hematologic disorders, or immune disorders, among others. In certain embodiments, the pharmaceutical compositions of 5-azacytidine which are parenterally administered to subjects in need thereof to treat a cancer or a hematological disorder, such as, for example, Myelodysplastic syndromes (MDS), acute myelogenous leukemia (AML).
IN4706CH2013 2013-10-18 2013-10-18 IN2013CH04706A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN4706CH2013 IN2013CH04706A (en) 2013-10-18 2013-10-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN4706CH2013 IN2013CH04706A (en) 2013-10-18 2013-10-18

Publications (1)

Publication Number Publication Date
IN2013CH04706A true IN2013CH04706A (en) 2015-04-24

Family

ID=54398391

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4706CH2013 IN2013CH04706A (en) 2013-10-18 2013-10-18

Country Status (1)

Country Link
IN (1) IN2013CH04706A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022002905A1 (en) * 2020-07-01 2022-01-06 Sandoz Ag Parenteral pharmaceutical composition comprising azacitidine in dmso

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022002905A1 (en) * 2020-07-01 2022-01-06 Sandoz Ag Parenteral pharmaceutical composition comprising azacitidine in dmso

Similar Documents

Publication Publication Date Title
PH12016500094A1 (en) Autotaxin inhibitors
PH12016500933A1 (en) Novel combination treatment for acute myeloid leukemia (aml)
MX359989B (en) Antiviral drugs for treatment of arenavirus infection.
PH12013502565A1 (en) Substituted imidazopyridinyl-aminopyridine compounds
WO2017059385A8 (en) 11,13-modified saxitoxins for the treatment of pain
MX2015014947A (en) Substituted5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones.
IN2015DN03327A (en)
WO2014190163A3 (en) Combination therapy for mds
PH12014501913A1 (en) New 5-alkynyl pyridine
MD20150035A2 (en) Bruton's tyrosine kinase inhibitors
MX2016007311A (en) Methods for treating cancers.
MX2020010375A (en) New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds.
MD4643B1 (en) Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same
PH12015502747A1 (en) Novel compounds for the treatment of cancer
MX2020012611A (en) High surface-area lyophilized compositions comprising arsenic for oral administration in patients.
AU2018256668A1 (en) Combination therapy comprising an inhibitor of JAK, CDK and PIM
MD4793C1 (en) New isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them
TN2015000267A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
TN2017000256A1 (en) Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereof
WO2014067960A3 (en) Functionalized 9-bromo-camptothecin derivatives
IN2013CH04706A (en)
MX2016004094A (en) Pharmaceutical composition comprising capecitabine and cyclophosphamide.
IN2013MU01226A (en)
WO2015195786A3 (en) Methods for treating cancers using oral formulations of cytidine analogs
IN2013CH05858A (en)